Rasoul Baharlou

1.0k total citations
55 papers, 783 citations indexed

About

Rasoul Baharlou is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Rasoul Baharlou has authored 55 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Rasoul Baharlou's work include Psoriasis: Treatment and Pathogenesis (6 papers), Hepatitis B Virus Studies (5 papers) and Mesenchymal stem cell research (5 papers). Rasoul Baharlou is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Hepatitis B Virus Studies (5 papers) and Mesenchymal stem cell research (5 papers). Rasoul Baharlou collaborates with scholars based in Iran, Sweden and Canada. Rasoul Baharlou's co-authors include Mohammad Reza Atashzar, Jafar Karami, Abbas Ahmadi Vasmehjani, Hamid Abdollahi, Ramazan Rezaei, Mohammad Hassan Davami, Ahmad Ghanizadeh, Fatemeh Faraji, Nader Tajik and Saiedeh Erfanian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Frontiers in Immunology.

In The Last Decade

Rasoul Baharlou

52 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rasoul Baharlou Iran 15 278 210 190 112 78 55 783
Adam P. Cribbs United Kingdom 20 687 2.5× 189 0.9× 460 2.4× 189 1.7× 86 1.1× 58 1.4k
Bernard Gregory United Kingdom 16 375 1.3× 182 0.9× 561 3.0× 103 0.9× 93 1.2× 18 1.2k
Florinda Battaglia Italy 18 249 0.9× 193 0.9× 588 3.1× 164 1.5× 58 0.7× 24 1.1k
Karin Wagner Austria 17 355 1.3× 123 0.6× 174 0.9× 65 0.6× 27 0.3× 31 815
Carolina Sellitto Italy 7 388 1.4× 199 0.9× 376 2.0× 195 1.7× 11 0.1× 8 976
Annie Mirsoian United States 11 215 0.8× 297 1.4× 383 2.0× 43 0.4× 38 0.5× 18 852
Saparna Pai Australia 15 161 0.6× 128 0.6× 422 2.2× 52 0.5× 85 1.1× 24 848
Laura Tesmer United States 8 322 1.2× 217 1.0× 947 5.0× 117 1.0× 28 0.4× 9 1.6k
Jacques Mbongue United States 9 144 0.5× 96 0.5× 288 1.5× 23 0.2× 105 1.3× 12 572
Themis Alissafi Greece 18 313 1.1× 222 1.1× 751 4.0× 72 0.6× 18 0.2× 25 1.3k

Countries citing papers authored by Rasoul Baharlou

Since Specialization
Citations

This map shows the geographic impact of Rasoul Baharlou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasoul Baharlou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasoul Baharlou more than expected).

Fields of papers citing papers by Rasoul Baharlou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasoul Baharlou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasoul Baharlou. The network helps show where Rasoul Baharlou may publish in the future.

Co-authorship network of co-authors of Rasoul Baharlou

This figure shows the co-authorship network connecting the top 25 collaborators of Rasoul Baharlou. A scholar is included among the top collaborators of Rasoul Baharlou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasoul Baharlou. Rasoul Baharlou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esmaeili, Seyed‐Alireza, et al.. (2025). Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights. Stem Cell Research & Therapy. 16(1). 33–33. 13 indexed citations
2.
Rashidy‐Pour, Ali, Bahman Yousefi, Rasoul Baharlou, et al.. (2025). Role of the TLR signaling pathway in the pathogenesis of glioblastoma multiforme with an emphasis on immunotherapy. Biochemistry and Biophysics Reports. 43. 102149–102149. 1 indexed citations
4.
5.
Esmaeili, Seyed‐Alireza, et al.. (2024). Berberine: A natural modulator of immune cells in multiple sclerosis. Immunity Inflammation and Disease. 12(3). e1213–e1213. 5 indexed citations
6.
Baharlou, Rasoul, et al.. (2024). Peptide Derivatives of Human and Rabbit Cathelicidin Reduce Inflammatory Cytokines in Peripheral Blood Mononuclear Cells of Rheumatoid Arthritis Patients. International Journal of Peptide Research and Therapeutics. 30(2). 1 indexed citations
7.
Haghmorad, Dariush, et al.. (2023). T-Cell Immune Responses and Immunological Factors Associated with Coronavirus Disease 2019 Progression as Predictors for the Severity of the Disease in Hospitalized Patients. International Archives of Allergy and Immunology. 184(6). 557–566. 3 indexed citations
9.
Nafissi, Nahid, Mohammad Esmaeil Akbari, Seied Rabi Mahdavi, et al.. (2022). The impact of intraoperative radiotherapy on breast cancer: focus on the levels of angiogenic factors. World Journal of Surgical Oncology. 20(1). 191–191. 10 indexed citations
10.
Abdollahi, Maryam, et al.. (2022). Anti-tumor effect of berberine on chronic lymphocytic leukemia cells. Medical Oncology. 39(12). 217–217. 2 indexed citations
11.
Kokhaei, Parviz, et al.. (2022). Multistrain Probiotics Supplement Alleviates Asthma Symptoms via Increasing Treg Cells Population: A Randomized, Double-Blind, Placebo-Controlled Trial. International Archives of Allergy and Immunology. 184(3). 291–301. 14 indexed citations
12.
Hemati, Maral, et al.. (2020). Apoptotic effect of berberine via Bcl‐2, ROR1, and mir‐21 in patients with B‐chronic lymphocytic leukemia. Phytotherapy Research. 35(4). 2025–2033. 16 indexed citations
13.
Baharlou, Rasoul, Nader Tajik, Mahdi Habibi‐Anbouhi, et al.. (2017). Generation and characterization of an anti-delta like ligand-4 Nanobody to induce non-productive angiogenesis. Analytical Biochemistry. 544. 34–41. 18 indexed citations
14.
Baharlou, Rasoul, et al.. (2016). HLA-DRB1 alleles of susceptibility and protection in Iranians with autoimmune hepatitis. Human Immunology. 77(4). 330–335. 16 indexed citations
15.
Baharlou, Rasoul, et al.. (2016). Reduced levels of T-helper 17-associated cytokines in the serum of patients with breast cancer: indicators for following the course of disease. Central European Journal of Immunology. 41(1). 78–85. 13 indexed citations
16.
Baharlou, Rasoul, Mohammad Hassan Davami, Abbas Ahmadi Vasmehjani, & Morteza Ebrahimi. (2016). Increased IL-17 and TGF-β serum levels in peripheral blood of patients with β-thalassemia major: implication for continual transfusions role in T helper17-mediated proinflammatory responses. TURKISH JOURNAL OF MEDICAL SCIENCES. 46(3). 749–755. 7 indexed citations
17.
Baharlou, Rasoul, et al.. (2015). Increased Interleukin-17 Transcripts in PeripheralBlood Mononuclear Cells, a Link Between T-Helper 17 and Proinflammatory Responses in Bladder Cancer. Iranian Red Crescent Medical Journal. 17(2). e9244–e9244. 7 indexed citations
18.
Dehghani, Ali, et al.. (2014). Effecting Factors on Academic Satisfaction Viewpoint of Jahrom University of Medical Sciences Students. Rāhburdhā-yi āmūzish dar ̒ulūm-i pizishkī. 7(3). 147–154. 2 indexed citations
20.
Jaberipour, Mansooreh, et al.. (2011). Increased IL-17 and IL-6 Transcripts in Peripheral Blood Mononuclear Cells: Implication for a Robust Proinflammatory Response in Early Stages of Breast Cancer. 2(1). 19–26. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026